Clin2
NCT07499050Likely a fitActive, not recruiting

Oral experimental weight-loss medication for Chinese adults

Healthy VolunteersOverweight or Obesity

Part of Hormones & metabolism clinical trials.

This trial tests an experimental oral medication (RO7795081) for weight loss in Chinese adults who are overweight or obese. The study aims to see if the drug is safe and how it affects the body in otherwise healthy participants.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are ethnically Chinese and live in mainland China.
  • Your body mass index (BMI) is 24 or higher (a measure of body fat based on height and weight).
  • You are in generally good health, without major medical conditions like unstable diabetes, heart disease, or severe thyroid/kidney problems.
  • You agree to follow contraception rules during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07274137Not yet recruiting· Phase 3
Weight-loss drug study for people with obesity or overweight

This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.

Beijing
NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT07792954Not yet recruiting· Phase 3
Weekly study medicine for weight loss in Chinese adults

This trial tests a once-weekly medicine, PF-08653944, to help Chinese adults with overweight or obesity lose weight. It aims to see if the medicine is more effective than a placebo, and could offer a new treatment option.

Hefei, Anhui
NCT07790861Not yet recruiting· Phase 3
Study of an oral weight loss medication in Chinese adults with overweight or obesity

This trial tests an investigational oral medication to help Chinese adults with overweight or obesity, plus related health issues, lose weight. It focuses on improving weight loss and overall health in this group.

Chengdu
NCT07110766Not yet recruiting· Phase 1
Study of MDR-001 for obesity or overweight people

This trial tests an experimental drug, MDR-001, to see if it is safe and helps with weight loss. It is for Chinese adults who are obese or overweight and have related health problems like pre-diabetes or high blood pressure.

Ch’ang-ch’un, Jilin
NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai

Hear when a new Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.